sendoxan tafla 50 mg
baxter medical ab* - cyclophosphamidum inn - tafla - 50 mg
sertralin bluefish filmuhúðuð tafla 100 mg
bluefish pharmaceuticals ab - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg
sendoxan stungulyfsstofn, lausn 1 g
baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 1 g
sendoxan stungulyfsstofn, lausn 500 mg
baxter medical ab* - cyclophosphamidum inn - stungulyfsstofn, lausn - 500 mg
sertralin krka (sertralin krka) filmuhúðuð tafla 50 mg
krka sverige ab - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg
sertralin wh filmuhúðuð tafla 50 mg
williams & halls ehf - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg
zoloft filmuhúðuð tafla 100 mg
upjohn eesv - sertralinum hýdróklóríð - filmuhúðuð tafla - 100 mg
zoloft filmuhúðuð tafla 50 mg
upjohn eesv - sertralinum hýdróklóríð - filmuhúðuð tafla - 50 mg
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - Æxlishemjandi lyf - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
sporanox hart hylki 100 mg
janssen-cilag ab - itraconazolum inn - hart hylki - 100 mg